Environmental, Social And Governance Report (Chinese edition)

Overview

The report presents Guobang Pharma's 2023 consolidated ESG performance, including revenue of 53.49 亿元 and 100% employee training coverage. It reports 4,231 year-end employees, including 1,448 women representing 34.22%. Environmental investment and operating costs totaled 1.65 亿元, and the company states that it operates an ISO14001 environmental management system.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: Chinese
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services